Amgen, Inc. is a leading biotechnology company that focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics. With a strong presence in the biopharmaceutical industry, the company is dedicated to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.

Amgen is committed to sustainability and has made significant strides in reducing its environmental impact. The company has set ambitious targets to reduce carbon emissions, water usage, and waste generation. Amgen's sustainability efforts are guided by its Environmental, Social, and Governance (ESG) framework, which emphasizes responsible business practices and transparency.

Amgen has been recognized for its efforts in sustainability, receiving various certifications and accolades. The company is actively working towards achieving carbon neutrality and has implemented numerous initiatives to minimize its carbon footprint. These initiatives include investing in renewable energy, enhancing energy efficiency, and optimizing resource use across its operations.

Furthermore, Amgen is committed to ethical sourcing and responsible supply chain management, ensuring that its products are manufactured in an environmentally and socially responsible manner. The company also engages with stakeholders to promote sustainability and drive positive change within the industry.

Despite these efforts, there is limited publicly available information on specific sustainability metrics and progress. However, Amgen continues to prioritize sustainability as a core component of its business strategy, striving to make a positive impact on the environment and society.